Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Ormond Beach, FL
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Sebastian, FL
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Sebastian, FL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Vero Beach, FL
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Vero Beach, FL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Augusta, GA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Augusta, GA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Lawrenceville, GA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Marietta, GA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Marietta, GA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Galesburg, IL
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Galesburg, IL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Park Ridge, IL
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Louisville, KY
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Lafayette, LA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Lafayette, LA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Grand Rapids, MI
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Kalamazoo, MI
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Branson, MO
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Branson, MO
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Billings, MT
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Billings, MT
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Great Falls, MT
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Great Falls, MT
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Albany, NY
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Albany, NY
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Armonk, NY
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Armonk, NY
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Great Neck, NY
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Great Neck, NY
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Wilmington, NC
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Wilmington, NC
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Dayton, OH
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Pottsville, PA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Pottsville, PA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Sayre, PA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Sayre, PA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Greenville, SC
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Greenville, SC
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Chattanooga, TN
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Memphis, TN
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Dallas, TX
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Tyler, TX
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Tyler, TX
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Chesapeake, VA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Norfolk, VA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Spokane, WA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Spokane, WA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Appleton, WI
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Appleton, WI
Click here to add this to my saved trials
Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma
Sentinel Lymph Node Localization and Biopsy for Conjunctival and Eyelid Melanoma
Status: Enrolling
Updated:  3/13/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma
Sentinel Lymph Node Localization and Biopsy for Conjunctival and Eyelid Melanoma
Status: Enrolling
Updated: 3/13/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC
Phase II Trial of Pulsed Paclitaxel With Concurrent Radiotherapy,and Adjuvant Chemotherapy in Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/13/2018
Brody School of Medicine at East Carolina University
mi
from
Greenville, NC
Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC
Phase II Trial of Pulsed Paclitaxel With Concurrent Radiotherapy,and Adjuvant Chemotherapy in Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/13/2018
Brody School of Medicine at East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis
Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis
Status: Enrolling
Updated:  3/13/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis
Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis
Status: Enrolling
Updated: 3/13/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Doctor-Recommended Home-Based Exercise Program or Relaxation Training in Improving Physical Function and Controlling Symptoms in Patients With Stage IV or Recurrent Colon Cancer That Cannot Be Removed By Surgery
Comparative Study of Oncologist Recommended, Home-Based Exercise Program and Relaxation Training for Physical Functioning and Symptom Control in Colon Cancer Patients
Status: Enrolling
Updated:  3/13/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Doctor-Recommended Home-Based Exercise Program or Relaxation Training in Improving Physical Function and Controlling Symptoms in Patients With Stage IV or Recurrent Colon Cancer That Cannot Be Removed By Surgery
Comparative Study of Oncologist Recommended, Home-Based Exercise Program and Relaxation Training for Physical Functioning and Symptom Control in Colon Cancer Patients
Status: Enrolling
Updated: 3/13/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
Status: Enrolling
Updated:  3/13/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
Status: Enrolling
Updated: 3/13/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy
A Phase I/II Trial of AEZS-108 in Locally Advanced Unresectable or Metastatic Luteinizing Hormone-releasing Hormone(LHRH) Positive Urothelial Carcinoma Patients Who Failed Platinum Based Chemotherapy
Status: Enrolling
Updated:  3/13/2018
University of Miami Miller School of Medicine
mi
from
Miami, FL
A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy
A Phase I/II Trial of AEZS-108 in Locally Advanced Unresectable or Metastatic Luteinizing Hormone-releasing Hormone(LHRH) Positive Urothelial Carcinoma Patients Who Failed Platinum Based Chemotherapy
Status: Enrolling
Updated: 3/13/2018
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy
A Phase I/II Trial of AEZS-108 in Locally Advanced Unresectable or Metastatic Luteinizing Hormone-releasing Hormone(LHRH) Positive Urothelial Carcinoma Patients Who Failed Platinum Based Chemotherapy
Status: Enrolling
Updated:  3/13/2018
Univerity of Pennsylvania
mi
from
Philadelphia, PA
A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy
A Phase I/II Trial of AEZS-108 in Locally Advanced Unresectable or Metastatic Luteinizing Hormone-releasing Hormone(LHRH) Positive Urothelial Carcinoma Patients Who Failed Platinum Based Chemotherapy
Status: Enrolling
Updated: 3/13/2018
Univerity of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics
Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics
Status: Enrolling
Updated:  3/13/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics
Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics
Status: Enrolling
Updated: 3/13/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Reducing VA No-Shows: Evaluation of Predictive Overbooking Applied to Colonoscopy
Reducing VA No-Shows: Evaluation of Predictive Overbooking Applied to Colonoscopy
Status: Enrolling
Updated:  3/13/2018
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Reducing VA No-Shows: Evaluation of Predictive Overbooking Applied to Colonoscopy
Reducing VA No-Shows: Evaluation of Predictive Overbooking Applied to Colonoscopy
Status: Enrolling
Updated: 3/13/2018
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2
Phase I Study of Secondary Primary Tumor Prevention With Epidermal Growth Factor Receptor (EGFR), Tyrosine Kinase Inhibitor Erlotinib (OSI-774, Tarceva™), and Cyclooxygenase-2 (COX-2) Inhibitor (Celecoxib) in Early Stage (Stage I/II) Squamous Cell Carcinoma of Head and Neck
Status: Enrolling
Updated:  3/13/2018
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2
Phase I Study of Secondary Primary Tumor Prevention With Epidermal Growth Factor Receptor (EGFR), Tyrosine Kinase Inhibitor Erlotinib (OSI-774, Tarceva™), and Cyclooxygenase-2 (COX-2) Inhibitor (Celecoxib) in Early Stage (Stage I/II) Squamous Cell Carcinoma of Head and Neck
Status: Enrolling
Updated: 3/13/2018
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Treating NSCLC Minimal Stage IV With Curative Intent
A Pilot Study Treating Patients With Minimal Stage IV Non-Small Cell Lung Cancer (NSCLC) With Curative Intent
Status: Enrolling
Updated:  3/13/2018
Leo W. Jenkins Cancer Center
mi
from
Greenville, NC
Treating NSCLC Minimal Stage IV With Curative Intent
A Pilot Study Treating Patients With Minimal Stage IV Non-Small Cell Lung Cancer (NSCLC) With Curative Intent
Status: Enrolling
Updated: 3/13/2018
Leo W. Jenkins Cancer Center
mi
from
Greenville, NC
Click here to add this to my saved trials
Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
A Multidisciplinary Team-Based Approach to Mitigate the Impact of Androgen Deprivation Therapy in Prostate Cancer: A Randomized Phase 2
Status: Enrolling
Updated:  3/13/2018
UCSF Medical Center at Mount Zion
mi
from
San Francisco, CA
Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
A Multidisciplinary Team-Based Approach to Mitigate the Impact of Androgen Deprivation Therapy in Prostate Cancer: A Randomized Phase 2
Status: Enrolling
Updated: 3/13/2018
UCSF Medical Center at Mount Zion
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated:  3/13/2018
UCLA
mi
from
Los Angeles, CA
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated: 3/13/2018
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated:  3/13/2018
UC Irvine
mi
from
Orange, CA
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated: 3/13/2018
UC Irvine
mi
from
Orange, CA
Click here to add this to my saved trials
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated:  3/13/2018
UC Davis
mi
from
Sacramento, CA
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated: 3/13/2018
UC Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated:  3/13/2018
UCSD
mi
from
San Diego, CA
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated: 3/13/2018
UCSD
mi
from
San Diego, CA
Click here to add this to my saved trials
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated:  3/13/2018
UCSF
mi
from
San Francisco, CA
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated: 3/13/2018
UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer
A Phase 1b, Open Label, Dose Finding Study To Evaluate Safety, Pharmacokinetics And Pharmacodynamics Of Axitinib (Ag-013736) In Combination With Pembrolizumab (Mk-3475) In Patients With Advanced Renal Cell Cancer
Status: Enrolling
Updated:  3/13/2018
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer
A Phase 1b, Open Label, Dose Finding Study To Evaluate Safety, Pharmacokinetics And Pharmacodynamics Of Axitinib (Ag-013736) In Combination With Pembrolizumab (Mk-3475) In Patients With Advanced Renal Cell Cancer
Status: Enrolling
Updated: 3/13/2018
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer
A Phase 1b, Open Label, Dose Finding Study To Evaluate Safety, Pharmacokinetics And Pharmacodynamics Of Axitinib (Ag-013736) In Combination With Pembrolizumab (Mk-3475) In Patients With Advanced Renal Cell Cancer
Status: Enrolling
Updated:  3/13/2018
Massachusetts General Hospital
mi
from
Boston, MA
A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer
A Phase 1b, Open Label, Dose Finding Study To Evaluate Safety, Pharmacokinetics And Pharmacodynamics Of Axitinib (Ag-013736) In Combination With Pembrolizumab (Mk-3475) In Patients With Advanced Renal Cell Cancer
Status: Enrolling
Updated: 3/13/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials